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Summary.-Carcinoembryonic antigen-like substances in the urine of patients with
bladder carcinoma and of healthy male subjects occur in a wide range of average
molecular sizes. Some of these substances are glycoproteins giving reactions of
antigenic identity with carcinoembryonic antigen (CEA) derived from colorectal
carcinoma and occur in aggregation with proteins showing antigen specificities of
albumin, haptoglobin and the heavy chains of immunoglobulins G, A and M. Re-
coveries of CEA-like activities, following Sepharose 4B chromatography of urinary
materials of molecular size > 3 x 104, varied from 40 to 1530%. Treatment with
1 mol/l HC104 caused an apparent solubilization of 85% of the CEA-like activity of
such materials from the urine of a patient with bladder carcinoma and raised the
specific CEA-like activity of the solubilized product to 379O% of that of the untreated
materials.
THE oncofoetal relationship between
an antigen first thought to be specific for
carcinomata of the digestive system and
foetal gut was first described by Gold and
Freedman (1965). This carcinoembryonic
antigen (CEA) or other antigenically
related substances, were later shown to
occur in comparatively low concentrations
in a wide variety of normal tissues and in
generally higher concentrations in tissues
associated with increased cellular turnover
as a result of injury or disease, especially
in advanced and metastatic tumours and
in a variety of non-neoplastic inflam-
matory or regenerative disorders (Martin
and Martin, 1970; Freed and Taylor,
1972; Laurence et al., 1972; Reynoso et al.,
1972; Hall et al., 1972; Nery, Barsoum
and Bullman, 1973). In particular, such
substances have been detected by radio-
immunoassay in the urines of patients
bearing urothelial carcinomata (Hall et al.,
1972). Some of the properties of the
urinary component having a mean mole-
cular size (i.e. 2 x 105, Krupey, Gold and
Freedman, 1968) similar to that of CEA
derived from colorectal carcinomata have
been described (Nery et al., 1974). We
now describe the isolation and some pro-
perties of macromolecular aggregates con-
taining CEA-like activity from the urines
of patients with bladder (urothelial) carci-
noma and, in lesser amounts, of normal
subjects.
MATERIALS AND METHODS
Chemicals and reagents.-Sepharose gels
and Blue Dextran 2000 were obtained from
Pharmacia (GB) Ltd, London, W.5, gelatine-
treated cellulose diacetate strips (Cellogel)
from Reeve Angel Scientific Ltd, London,
S.E.1, goat anti-human serum components
from Miles-Seravac (Pty) Ltd, Maidenhead,
Berks., acrylamide and NN'-methylenebi-
sacrylamide from British Drug Houses,
Poole, Dorset and rabbit IgG from Wellcome
Research Laboratories, Beckenham, Kent.
Other chemicals and reagents were from
various commercial sources.
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32R. NERY, R. JAMES, A. L. BARSOUM AND H. BULLMAN
Apparatus.-Chromatographic columns
equipped with cooling jackets were obtained
from Pharmacia (G.B.) Ltd. The electro-
phoresis apparatus (ModelU77) andanalytical
polyacrylamide gel-electrophoresis apparatus
were from Shandon Scientific Co. Ltd,
London, N.W.10 andultrafiltration apparatus
(Model 2000) and membranes were from
Amicon Ltd, High Wycombe, Bucks.
Distilled water.-De-ionized douible dis-
tilled water prepared in an all glass apparatus
was used throughout.
Aqueous buffer solutions-.Phosphate
buffered saline solutions contained NaH2PO4
(50 mmol), NaCl (150 mmol) and NaN3
(3.1 mmol) per litre of solution adjusted to
pH 5-8 or 7-2 with 1 mol/l-NaOH. Phosphate
buffered saline-EDTA-rabbit IgG (pH 7.2)
contained NaH2PO4 (22.5 mmol), Na2HPO4
(52.5 mmol), NaCl (75 mmol), EDTA (0.8
mmol) and rabbit IgG (1 g) per litre of
solution. Barbitone (Veronal) buffer (pH 8 6)
contained sodium barbitone (50 mmol) and
barbitone (10 mmol) per litre of solution.
Borate buffer (pH 8.6) contained Na2B4O7,
10H20 (25.5 mmol) and boric acid (75 mmol)
per litre of solution. Borate buffered urea
(pH 8.6) contained urea (5 mol) per litre of
borate buffer.
Urines.-These were obtained from
patients with urothelial carcinoma at the
Royal Marsden Hospital. The specimens
were collected in sterile containers and stoired
at -20°C until required.
Goat anti-(carcinoembryonic antigen) anti-
serum.-This, monospecific for carcinoem-
bryonic antigen derived from colorectal
carcinoma, was prepared from goats im-
munized with a standard purified preparation
of the antigen as described by Darcy,
Turberville and James (1973).
Carcinoembryonic antigen.-All prepara-
tions were from human colorectal carcinomata
or their liver metastases. The standard
preparation was a gift from Dr C. W. Todd
(City of Hope National Medical Center,
Duarte, California) and was labelled with
1251 as described by Egan et al. (1972). Other
samples, kindly supplied by Dr C. Turberville
(Chester Beatty Research Institute) were
prepared as described by Krupey et al. (1968).
The antigen is a glycoprotein (or a mixture of
glycoproteins) of average molecular weight
2 x 105. Briefly, the antigen was prepared
by extracting homogenized tumour tissue
with aqueous 1 mol/l-HClO4 and fractionating
the solubilized components by successive gel
filtration on columns (10 cm x 89 cm) of
Sepharose 4B and Sephadex G200. Unless
otherwise stated, carcinoembryonic antigen
refers to preparations obtained in this way,
without further purification. Generally, such
materials show 60-100% of the antigenic
activity in radioimmunoassay Qf the more
highly purified standard substance.
Radioimmunoassay.-This was performed
by the double antibody procedure of Egan
et al. (1972) as modified by Laurence et al.
(1972). Carcinoembryonic antigen-like
activity of urinary preparations so deter-
mined is expressed as weight-equivalent
antigenic activity, this being arbitrarily
defined as that weight or concentration ofthe
standard antigen required to give an equi-
valent inhibition in the radioimmunoassay.
For brevity, this activity is referred to
throughout the text as antigenic activity.
Gelfiltration chromatography.-The packed
columns were developed overnight, or longer,
with phosphate buffered saline (pH 5.8) at
4°C until reproducible void volumes (V0) (as
determined by the exclusion of Blue Dextran
2000) were obtained. Fractions (25 ml) were
collected from a Sepharose 4B column (bed
dimensions 10cm x 80cm; V0 1.625 1) and
fractions (4.7 ml) from a Sepharose 2B
column (bed dimensions 2-5 cm x 56 cm; V0
140 ml) at a flow rate of 1-3-1-5 ml/h/cm2
cross sectional area at 4°C. The E-280 of
effluent fractions was recorded continuously
with an LKB Uvicord recorder or manually
with a Unicam SP800 u.v. spectrophotometer.
The antigenic activity of selected fractions
was determined as a routine by radio-
immunoassay. Appropriate fractions were
combined, dialysed against several changes
of distilled water at 4°C for 3 days and freeze
dried.
Disc electrophoresis on polyacrylamide gels.
-This was performed by the method of
Ornstein and Davis (Davis, 1964). The
sample (20-30 jig) was dissolved in the appro-
priate electrophoresis buffer (10-15 ,l) con-
taining, where appropriate, dissolved urea
(50-75 ,umol).
Immunodiffusion in agarose.-This was
performed on glass microscope slides
(7-6 cm x 2-5 cm) or in petri dishes coated to
a depth of 2 mm with a 1.5% (w/v) solution
of agarose in barbitone buffer. Preliminary
immunotitration experiments were performed
to establish optimum antigen/antiserum dilu-
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tions required for the formation of visible
immunoprecipitates.
Electrophoresis and immunoelectrophoresis
in Cellogel.-These were performed as de-
scribed by Nery et al. (1974).
RESULTS
Preliminarypreparationofurinaryfractions
(a) Urines clarified by centrifugation
at 2200 g at 4°C for 30 min were ultra-
filtered through a PM-30 membrane in the
Amicon ultrafiltration apparatus with
stirring at 4°C. For each litre of urine,
the material retained on the filter was
washed with distilled water (2 x 100 ml)
and dissolved in distilled water (25 ml).
The resulting solution was dialysed in
Visking tubing at 4°C for 24 h against one
change of distilled water and freeze dried.
This gave approximately 0-08-041 g and
0-85-1-1 g of freeze dried product/I of
pooled urine (urine 6; Table) from healthy
male subjects and of urine (urines 1-5,
Table) from individual patients with
bladder carcinoma respectively. The pro-
ducts showed 50 and 9-95 ng of antigenic
activity/mg of residue, as determined by
radioimmunoassay (Table, columns Sa of
urine 6 and of urines 1-5, respectively).
(b) The aqueous solution (750 ml) ofthe
material retained on the PM-30 membrane
from a sample (30 litre) of urine 5 (Table)
from a patient with bladder carcinoma
contained 25-65 mg of antigenic activity
as determined by radioimmunoassay. A
sample (250 ml) of the solution was (i)
dialysed and freeze dried as in (a) to give
a product (9 g) showing 950 ng of anti-
genic activity/mg of residue. At 4°C, the
remainder of the solution was (ii) treated
with an equal volume of 2 mol/l-HCl04,
stirred for 30 min, centrifuged at 2200 g
for 30 min and the clear supernatant
dialysed in Visking tubing for 3 days
against 6 changes of distilled water and
freeze dried. The product (4.04 g) showed
3600 ng ofantigenic activity/mgofresidue.
This indicated that the acid extraction
procedure solubilized approximately 85%
of the antigenic activity but increased the
specific (w/w) antigenic activity of the
solubilized product to 379% of that ofthe
freeze dried product obtained from the
same urine as described in (b) (i).
(c) Urine, collected by catheterization
of the bladder of a female patient with
bladder carcinoma, was treated with
sodium azide to a final concentration of
0-02% (w/v) and divided into 2 equal
portions. Corresponding portions were
combined as collected and stored (i) at
4°C for approximately one week during
collection or (ii) frozen at -20°C for a
total period of approximately one month
during, and after, collection. Sample (i)
(6 1) was centrifuged at 2200 g at 4°C for
30 min and the supernatant solution con-
centrated to approximately 100 ml by
ultrafiltration through aPM-30membrane,
diluted with distilled water (3 X 100 ml)
and the volume of the diluted solution
reduced to approximately 45 ml after each
dilution step. The final solution was
diluted with 0-1 mol/l phosphate buffered
saline (pH 5-8, 50 ml), the total volume
adjusted to 100 ml with distilled water and
the mixture centrifuged as before. The
supernatant solution, as determined by
radioimmunoassay, contained 51 ng of
antigenic activity/ml of solution, i.e. a
total antigenic activity of 5-1 mg. Sample
(ii) (6 1) was processed as in (a) above; the
freeze dried product (5-5 g), as determined
by radioimmunoassay, contained 950 ng
of antigenic activity/mg of residue, i.e. a
total antigenic activity of 5-2 mg or
approximately 102% ofthe total antigenic
activity recovered by procedure (c) (i).
This indicated that freezing and thawing
of the urine did not significantly alter the
antigenic activity of the same urine not
subjected to such processes.
Sepharose 4B chromatography
A sample (4-6 g) of each freeze dried
product obtained as described in (a), (b)
and (c) (ii) above, dissolved in phosphate
buffered saline (pH 5-8) at a concentration
of 10% (w/v), was centrifuged on a bench
centrifiuge to remove small amounts of
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insoluble materials. Each resulting solu-
tion, the centrifuged final solution de-
scribed in (c) (i) above and carcino-
embryonic antigen (5 mg), obtained as a
Sephadex G200 fraction from colorectal
carcinoma (Krupey et al., 1968) and
dissolved in the same buffer (10 ml) were
severally chromatographed on a column of
Sepharose 4B. Representative elution
profiles showing the main features of the
results are shown in Fig. 1, as follows: (1)
There was a wide distribution of antigenic
activity, according to molecular size, in
all the samples. (2) Two main peaks of
antigenic activity (peaks A and C of
A * B-
curves 1, 2 and 3) were seen in all but one
(see curve 4, Fig. 1, obtained from urine 4,
Table) oftheelutionprofiles: one (UCEA-3,
peak A) was excluided by the gel and the
other (UCEA-1, peak C) eluted almost
coincidentally with CEA derived from
colorectal carcinoma (curve 5). The
single main peak of activity shown by
urine 4 was of size intermediate between
that of UCEA-l and of UCEA-3. (3)
Perchloric acid treatment of the fraction
ofurine 5 (urine 5a, Table) retained by the
PM-30 membrane caused a relative de-
crease and increase respectively of the
activities of peaks A and B (curve 3) in
It
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FIG. 1. Sepharose 4B chromatography of CEA-like urinary components: Elution of antigenic
activity: curves I (0) and 4 (7), urinary components ofmolecularweight approximately > .3 x 104
from two patients with bladder carcinoma; cuive 2 (A), similar components from healthy male
subjects; curve 3 (-), a pcrchloric acid soluble fraction of similar components from a patient with
bladder carcinoma; curve 5 (A), CEA from colorectal carcinoma.
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relation to those of the corresponding
peaks (curve 1) of the untreated fraction
of urine 5. (4) A specimen of urine
obtained by catheterization ofthe bladder
ofa female patient with bladder carcinoma
(see (c) (i) and (c) (ii) above), and hence
uncontaminated with cervical secretions,
showed an activity profile similar to that
shown in curve 1. This profile was similar
whether ((c) (ii) above) or not ((c) (i)
above) freezing, thawing and freeze drying
procedures preceded gel filtration. (5)
Compared with the urines (urines 1-3 and
5, Table, curve 1) from the patients with
bladder carcinomata, the pooled urine
(urine 6, Table) from healthy male subjects
contained relatively larger proportions of
CEA-like components of mean molecular
size smaller than that of CEA derived
from colorectal carcinoma. The effluents
from the Sepharose 4B column were
combined into 4 fractions (A-D) as
indicated in Fig. 1. Each combined
fraction was dialysed at 4°C in Visking
tubing against 6 changes of distilled water
for 3 days and freeze dried. The antigenic
L-
a
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u
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3
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activities of the freeze dried products and
of the starting materials (Table) were
determined by radioimmunoassay. The
results (Table) showed a wide distribution
of this activity in all the fractions, a wide
variation (from 0 04 to 10.0) of the
UCEA-3/UCEA-1 (ACIC,) ratio and re-
coveries of CEA-like activities ranging
from 40 to 1530%. The highest relative
proportion (D,/CC) of CEA-like compo-
nents of molecular size smaller than that
(i.e. 2 x 105, Krupey et al., 1968) of CEA
derived from colorectal carcinoma again
occurred in the combined urines from
healthy male subjects.
Sepharose 2B chromatography
A sample (10 mg) of UCEA-3 (17 mg),
obtained after dialysis and freeze drying of
combined effluents (fraction A, Fig. 1) of
urine 5a (Table), was dissolved in phos-
phate buffered saline (pH 5f8; 5 ml) and
chromatographed on a column of Sepha-
rose 2B. Radioimmunoassay of effluent
fractions showed (Fig. 2) 2 peaks of CEA-
like activity: a major broad peak and a
Ve/Vo
FI(G. 2. Sepharose 2B chromatography: Elution of antigenic activity (0) an( r280 ( ) from the
perchloric aci(l soluble Sepharose 4B sub-fraction A (Fig. 1) of urine (5a, Table) from a patient with
bladder carcinoma. Elutioin of antigenic activity from CEA (lerive(l from colorectal carcinoma
(-) and from UCEA-1 (L). Elution of E280 from Blue Dextran 2000 (- --).
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minor peak of lower nmean molecular size
similartothatgivenwhenpurified (Krupey
et al., 1968) CEA (2 mg) derived from
colorectal carcinoma wassimilarly chroma-
tographed.
Polyacrylamide gel electrophoresis
The following samples were used: (1)
UCEA-1 (20 ,ug) purified by successive gel
filtration on Sepharose 4B and Sephadex
G200 followed by Cellogel block electro-
phoresis (Nery et al., 1974); (2) CEA
(20 jag) derived from colorectal carcinoma
and obtained as a Sephadex G200 fraction
(Krupey et al., 1968) and (3) UCEA-3
(40 ,ug) obtained after dialysis and freeze
drying of the Sepharose 4B fraction A
(Fig. 1) of urine 5 (Table). Duplicate
samples were subjected to electrophoresis
in 150% (w/v) polyacrylamide gels in
borate buffer at 3 mA/gel for 7 h in the
absence (gels 1-3 respectively) and pr.-
sence (gels 4-6 respectively) of 5 mol/l
urea. The gels were stained for glyco-
proteins by the periodate-Schiff procedure
of Zacharius et al. (1969) and for proteins
with Coomassie Brilliant Blue. The
results (Fig. 3) showedapparentlyidentical
protein and glycoprotein bands for UCEA-
1 (gel 1) and CEA (gel 2) having an
electrophoretic mobility of 06-0 7 mm/h
per mA, unchanged in the presence ofurea
(gels 4 and 5 respectively). By contrast,
UCEA-3 penetrated the gel poorly in the
absence of urea (gel 3) but released, in its
presence (gel 6), a diffuse glycoprotein
band having a mean electrophoretic
mobility similar to that of the other 2
antigens.
Immunoelectrophoresis on ('elloqel strips
Samples of CEA (30 ,ug) and of Sepha-
rose 4B sub-fractions A and C (Fig. 1) of
urine 5, Table (7 mgand 5 mgrespectively),
were treated with borate buffered urea
(100 ,ul for the last 2; 120 1,d for the first).
All but the second gave clear solutions; the
second was shaken gently at room tem-
perature overnight and centrifuged for
15 min in a bench centrifuge to give a
clear supernatant solution. Triplicate
samples (40 pil) of each solution were
applied on strips (2.5 cm x 14 cm) of
Cellogel and subjected to electrophoresis
in borate buffer at 2 mA/cm strip width
for 18 min as described by Nery et al.
(1974). One electrophoretogram was sub-
jected to immunodiffusion against mono-
specific goat anti-CEA antiserum in a
moist chamber at room temperature for
60 h, washed by agitation at room tem-
perature in several changes of barbitone
buffer for 16 h and stained with nigrosine.
An apparently identical precipitin arc was
given by all the samples; UCEA-3 (Sepha-
rose 4B sub-fraction A) also give a slower,
less well defined precipitin line (Fig. 4).
The other electrophoretograms, stained
for glycoprotein by the periodate-Schiff
procedure of Bodman (1960), asnd for
Fi(O. 3. Polyacrylamide gel electrophoresis: Electrophoresis was performed in borate buffer in 15°/
(w/v) gels at 3 mA/gel for 7 h in the absence (gels 1-3) and presence (ge!s 4-6) of urea. Gels I and 4,
UCEA-1 (purified Sepharose 4B sub-fraction C, Fig. 1) and gels 3 and C, UCEA-3 (Sepharose 4B
sub-fraction A, Fig. 1) from the urine of a patient with bladder carciinoma; gels 2 aI(1 5, CEA
dlerived from colorectal carcinoma.
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FIG. 4. Immunoelectrophoresis on Cellogel strips: Lanes 1 and 3 contained the dialysed freeze
dried products obtained from the Sepharose 4B sub-fractions A and C, respectivelv, of urine 5
(Table) and lane 2 contained CEA derived from colorectal carcinoma. Immunodiffusion was
against undiluted monospecific goat anti-CEA antiserum.
proteins with Coomassie Brilliant Blue,
showed the presence of a major band,
stained with both reagents, which was
coincident with the centre of the common
precipitin arc and had a mean electro-
phoretic mobility of 50-52 mm/h per mA.
Otherunidentifiedbandswerealsorevealed
for the urinary fractions.
Identification by immunodiffusion of some
component8 of the UCEA-3 complex
Petri dishes were coated to a depth of
2 mm with a 1-5% (w/v) solution of
agarose in barbitone buffered saline. The
peripheral wells (Fig. 5) contained: (1)
UCEA-1 (2 mg) obtained from the urine of
a patient with bladder carcinoma and
purified finally by Cellogel block electro-
phoresis as described by Nery et al. (1974);
(2) undiluted monospecific goat anti-CEA
antiserum (30 ,ld) (Darcy et al., 1973); (3)
CEA (20 ,tg) derived from colorectal
carcinoma and purified finallyonSephadex
G200 as described by Krupey et al. (1968);
and 4-10, undiluted goat anti-human
serum or goat anti-human serum com-
ponents (20 ll) as follows: (4) anti-IgG
(y-chain monospecific); (5) anti-whole
human serum; (6) anti-IgA (a-chain mono-
specific); (7) anti-IgD (8-chain mono-
specific); (8) anti-IgM (,u-chain mono-
specific); (9) anti-albumin and (10) anti-
haptoglobin. The centre wells (Fig. 5a)
contained UCEA-3 (4 mg), obtained after
dialysis and freeze-drying of combined
Sepharose 4B fraction A (Fig. 1) ofurine 5
(Table); the centre wells (Fig. 5b) con-
tained the corresponding dialysed and
freeze dried fraction of the combined
urines (urine 6, Table) of healthy male
subjects. Samples of the antigens were
transferred to the appropriate wells as
solutions in barbitone buffered saline
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FIG. 5. Identificatiof by immunodiffusion of some components of Sepharose 4B sub-fraction A
(UCEA-3): Wells in agarose gels contained: (1) UCEA-1; (2) undiluted monospecific goat anti-CEA
antiserum; (3) CEA derived from colorectal carcinoma, and (4-10) undiluted goat anti-whole human
serum or undiluted goat anti-human serum components, as follows: (4) anti-IgG (y-chain mono-
specific); (5) anti-whole; (6) anti-IgA (a-chain monospecific); (7) anti-IgD (6-chain monospecific);
(8) anti-IgM (1t-chain monospecific); (9) anti-albumin and 10, anti-haptoglobin. The centre wells
contained Sepharose 4B sub-fraction A of urine (urine 5, Table) from a patient with bladder
carcinoma (Fig. 5a) or of urine (urine 6) from healthy male subjects (Fig. 5b).
(50-100 jdl). After immunodiffusion in a
moist chamber at room temperature for
72 h, the immunograms were washed in
several changes of the same buffer by
periodical agitation at room temperature
for 24 h and photographed. The results
(Fig. 5 and Table) show the presence of
components of the UCEA-3 complex
giving reactions of antigenic identity with
CEA derived from colorectal carcinoma
and others having antigenic specificities
characteristic of albumin, hiptoglobin
and the heavy chains ofIgG and IgA. The
other UCEA-3 complexes (Fractions A,
Fig. 1, of urines 1-3, Table) also showed
the presence of these components in
varying amounts; in addition, those from
urines 1 and 3 showed the presence of a
component having antigenic specificity
characteristic of the heavy chain of IgM.
Fraction A (Fig. 1) of the perchloric acid
soluble components of urine 5 (Table)
showed the presence ofsubstances bearing
the IgG and IgM, but not the other
specificities. The corresponding complex
from fraction A (Fig. 1) of urine (urine 6,
Table) from healthy male subjects showed
components having the albumin and IgG
but not the haptoglobin, IgA or IgM
specificities detectable under the condi-
tions described (Fig. 5b). The results are
summarized in the Table.
DISCUSSION
The present study describes 3 appar-
ently characteristic properties of urinary
substances which cross-react during radio-
immunoassay with CEA derived from
colorectal carcinoma. These properties
are heterogeneity in molecular size, a
pronounced tendency to occur in large
multi-component aggregates and low
specific activity, i.e. weight equivalent
antigenic activity per unit weight of the
substance.
Heterogeneity in molecular size was
evident from the wide distribution of
antigenicactivity inSepharose 4Bfractions
of all samples of urines investigated
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(Fig. 1 and Table). Conceivably, this
heterogeneity might have resulted from
interactions of a single CEA-like glyco-
protein (Component C, Fig. 1) having a
mean molecular size approximately similar
to that (2 x 105; Krupey et al., 1968) of
CEA derived from colorectal carcinoma;
the larger (A and B, Fig. 1) or smaller (D)
components would then have arisen from
aggregation or hydrolysis by urinary
hydrolases, respectively, of component C.
This appears unlikely for several reasons:
(a) A Sephadex G200 fraction of compo-
nent C (UCEA-1) derived from the urine of
a patient with bladder carcinoma and a
similar fraction of CEA derived from
colorectal carcinoma were not appreciably
degraded after incubation at 37°C for 16 h
of solutions of the antigens in urine from
healthy subjects or from patients with
bladder carcinoma (James, Neville and
Nery, unpublished). (b) The specific
activities ((b), Table) of components S
and A-D (Table) of the various urines
showed wide variations and no consistent
pattern emerged. (c) The highest specific
activity (0.51%) occurred in component
C of a perchloric acid soluble fraction
(urine 5a) of urine from a patient
with bladder carcinoma. Further purifi-
cation ofthis component by successive gel
filtration on Sephadex G200 and Cellogel
block electrophoresis gave a final product
having a specific activity of30 (Neryetal.,
1974). By contrast, the corresponding
Sepharose 4B and SephadexG200fractions
of perchloric acid extracts of colorectal
carcinoma contained specific activities of
40-80% and 60-100% respectively
(Krupey et al., 1968; Coligan et al., 1973;
Turberville et al., 1973).
Some urinary CEA-like substances
occurred in large multi-component aggre-
gates. The aggregations were probably
neither due to contamination with cervical
secretions nor induced by experimental
procedures involving freezing and thawing
of the urines, followed by freeze drying of
the various dialysed fractions. Urine
collected by catheterization of the bladder
ofapatientwithbladdercarcinoma showed
similar distributions of antigenic activity
during Sepharose 4B chromatography
whether such procedures were employed or
eliminated. Sepharose 4B fractions (Fig. 1
and Table), showing mean molecular
weights of over 20 million (Fraction A)
and intermediate (Fraction B) between
this and 2 x 105 (i.e. the mean molecular
weight of fractions C and of CEA derived
from colorectal carcinoma) released com-
ponents which were qualitatively indistin-
guishable from CEA derived from colo-
rectal carcinoma in several respects: (a)
Such components were released (i) during
perchloric acid extraction of urine 5
(compare curves 1 and 2 ofFig. 5, obtained
before and after extraction, respectively)
and during gel filtration on Sepharose 2B
(Fig. 2) of the perchloric acid soluble
Sepharose 4B fraction A ofthe same urine,
indicating similarity in molecular size and
(ii) during electrophoresis in polyacryl-
amide gels (Fig. 3) and immunoelectro-
phoresis on Cellogel (Fig. 4), indicating
similarity in electrophoretic mobility and
antigenic properties. (b) Precipitin lines
of antigenic identity formed during im-
munodiffusion in agarose against mono-
specific anti-CEA antiserum (Fig. 5)
indicated the presence of common or
cross-reacting antigenic determinants. (c)
Reactions characteristic of glycoproteins,
i.e. formation of complexes with borate
ions and staining with periodate-Schiff
reagent and with Coomassie Brilliant
Blue, were given by both substances
(Fig. 3 and 4). (d) Treatment ofSepharose
4B fraction A (Fig. 1) of urine 5 (Table)
with 5 mol/l urea caused disaggregation
releasing at least 2 components bearing
antigenic similarities to CEA derived from
colorectal carcinoma (Fig. 4). Urinary
components showing reactions of partial
antigenic identity with CEA have also
been detected (Darcy, personal com-
munication, and Nery et al., 1974).
Sepharose 4B fractions A and B also
contained substances (in variable amounts
and occurrence) showing antigenic speci-
cities of albumin, haptoglobin and the
heavy chains of immunoglobulins G, A
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and M (Fig. 5). The presence ofthe heavy
chain IgM specificity (Nery and James,
unpublished) in preparations of UCEA-1
(mean mol. wt 2 x 105) may thus be due
to the separated ,u-chains and not to the
intact IgM molecule (mol. wt. 9 x 105).
Further, perchloric acid solubilized only
part (7900) ofthe CEA-like activity giving
a macromolecular aggregate (Fraction A,
Fig. 1 of urine 5, Table) containing
immunoglobulin specificities (Table); it is
thus possible that some of the immuno-
globulins or their component heavy chains
are attached to CEA-like components of
varying carbohydrate composition by
covalent, e.g. disulphide, bonds not dis-
rupted by acid treatment and resulting in
precipitation of the CEA-like components
of low carbohydrate composition.
The low specific activity (columns (b)
of Sepharose 4B fractions S and A-D,
Table) was not significantly different in
urine (urine 6) of healthy male subjects
and in urine (urines 1-5) ofcancer patients.
The higher antigenic activity found in the
latter urines (Hall et al., 1972) might thus
have resulted in part from the higher
concentration (approximately 1 g/l and
0-1 g/l of urine from the cancer patients
and normal subjects respectively) of
urinary components containing CEA-like
activity and having an approximate
molecular weight greater than 3 x 104.
Since an approximately ten-fold difference
in urinary titre between the cancer
patients and healthy subjects has not been
observed (Table, column C), other deter-
mining factors might have been the
multiplicity, competitive reactivity and
accessibility of CEA-like antigenic deter-
minant groups. Such groups might have
been hidden in aggregates by direct com-
bination, e.g. with the immunoglobulin
components or by steric factors; they
might have been exposed during partial
disaggregations induced during gel filtra-
tion on Sepharose 4B, resulting in re-
coveries of antigenic activities generally
greater than 100% and exceeding 1500%
in one case (urine 3, Table). The recovery
of less than 1000% observed in urine 4
(Table) might have been due to the
presence of dialysable CEA-like com-
ponents in some of the aggregates. The
presence of such components in urines of
patients with bladder carcinoma has been
reported (Nery et al., 1974). Some of
these components might have been freed
from aggregation and lost during the
extensive dialysis of the Sepharose 4B
fractions. Comparison of these fractions
of urine 4 shows the highest proportion of
antigenic activity in Fraction B before
(curve 4 of Fig. 1), but the lowest after
(0.9 ,ag or 3.6% of the total eluted
activity) the fractions were dialysed. The
dialysed fractions also showed the highest
relative proportions of CEA-like com-
ponents of molecular sizes greater
(Ac + BC/CC, Table) than that of fraction
C, with the bulk (80%) of the non-dialy-
sable activity now occurring in the
fraction (Fraction A) ofgreatest molecular
size.
This and other studies (Martin and
Martin, 1970; Freed and Taylor, 1972;
Laurence et at., 1972; Reynoso et al., 1972;
Nery et al., 1973) showing the presence of
substances giving positive values during
radioimmunoassays for CEA in both
normal and diseased states indicate that
such substances may represent a family of
antigenically related molecules. These
substances aregenerally secreted ingreater
amounts during injury and disease and
may differ from one another by, as yet
undetermined, structural modifications of
normal tissue components as a result of
impaired cellular metabolism.
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